After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NYSE-listed company operates within the Medical Instruments & Supplies industry segment, falling under the Healthcare sector. The current market capitalization of Resmed Inc is $36.60B. A total of 1.19 million shares were traded on the day, compared to an average of 1.07M shares.
In the most recent transaction, FARRELL PETER C sold 2,000 shares of RMD for 252.05 per share on Nov 12 ’25. After the transaction, the Director now owns 66,110 company shares. In a previous transaction on Nov 11 ’25, De Witte Jan sold 487 shares at 250.25 per share. RMD shares that Director owns now total 5,319.
Among the insiders who bought shares, Peter C Farrell acquired of 2,000 shares on Nov 12 ’25 at a per-share price of $252.05. In another insider transaction, De Witte Jan bought 487 shares at $250.25 per share on Nov 11 ’25.
Dividend
The income generated by dividends is an indication that a company is improving its financial position, which is why investors prefer companies paying dividends. Resmed Inc pays an annual dividend of $2.26, resulting in a dividend yield of 0.90%, and it has a price to earnings (P/E) ratio of 25.66.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, RMD has a high of $293.81 and a low of $199.92.
As of this writing, RMD has an earnings estimate of $2.71 per share for the current quarter. EPS was calculated based on a consensus of 13.0 estimates, with a high estimate of $2.83 per share and a lower estimate of $2.63. The company reported an EPS of $2.43 in the last quarter
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. RMD’s latest balance sheet shows that the firm has $273.71M in Cash & Short Term Investments as of fiscal 2022. There were $917.55M in debt and $689.30M in liabilities at the time. Its Book Value Per Share was $41.94, while its Total Shareholder’s Equity was $3.36B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for RMD is Buy with a score of 3.95.
